Cryotherapy Post-haemorrhoidectomy (CYPHER) Randomized Controlled Trial

Sponsor
Singapore General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06005727
Collaborator
(none)
50
1
2
21
2.4

Study Details

Study Description

Brief Summary

Haemorrhoids is a common problem with an estimated prevalence of 5 to 36%. Surgery is indicated in patients with grade 3 to 4 piles and in patients whom conservative measures have failed. There have been several surgical techniques described such as the Milligan- Morgan, Ferguson haemorrhoidectomy, stapled and laser haemorrhoidectomy. However, most patients experience different degrees of postoperative pain which may cause anxiety and dissatisfaction.

A relatively non-invasive and cost-effective technique targeting inflammation is cryotherapy which has been shown to decrease pain secondary to trauma, injury or disease. Cryotherapy has few deleterious side effects due to its non-pharmacologic nature and has become widespread in sports medicine to treat soft tissue damage.

Therefore, we aim to evaluate the role of cryotherapy in improving postoperative pain and outcomes among patients who undergo haemorrhoidectomy.

Condition or Disease Intervention/Treatment Phase
  • Device: Transanal ice pack
N/A

Detailed Description

Haemorrhoids is a common problem with an estimated prevalence of 5 to 36%. Surgery is indicated in patients with grade 3 to 4 piles and in patients whom conservative measures have failed. There have been several surgical techniques described such as the Milligan- Morgan, Ferguson haemorrhoidectomy, stapled and laser haemorrhoidectomy. However, most patients experience different degrees of postoperative pain which may cause anxiety and dissatisfaction.

Pain is an unavoidable side effect of any proctology operation. It arises from local inflammation in traumatized tissues which may cause stimulation of surrounding nociceptors. While adequate postoperative analgesia promotes patient recovery and satisfaction, narcotics for postoperative pain are also associated with numerous side effects.

A relatively non-invasive and cost-effective technique targeting inflammation is cryotherapy which has been shown to decrease pain secondary to trauma, injury or disease. Cryotherapy has few deleterious side effects due to its non-pharmacologic nature and has become widespread in sports medicine to treat soft tissue damage. Ice therapy has previously been shown to be safe and effect for postoperative analgesia in various procedures such as laparotomy, hernia repair, tonsillectomy, oral surgery but the evidence for its role in haemorrhoidectomy is lacking.

Therefore, we aim to evaluate the role of cryotherapy in improving postoperative pain and outcomes among patients who undergo haemorrhoidectomy. We hypothesize that intraoperative trans-anal ice pack insertion for patients after haemorrhoidectomy (conventional & stapled) will have lower postoperative pain scores with possibly decreased postoperative complications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Cryotherapy Post-haemorrhoidectomy (CYPHER) Randomized Controlled Trial
Actual Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transanal ice pack applied to hemorrhoidectomy wound for 1 minute

Transanal ice pack is applied to hemorrhoidectomy wound for 1 minute. After the surgery, standard postoperative analgesia and medications will be prescribed.

Device: Transanal ice pack
A condom is filled with 100ml of water and frozen to serve as a transanal ice pack. It is covered by sterile plastic dressing and applied to the hemorrhoidectomy wound for 1 minute after surgery is completed.

No Intervention: Standard postoperative care after hemorrhoidectomy

Standard postoperative analgesia and medications will be prescribed.

Outcome Measures

Primary Outcome Measures

  1. Pain score on postoperative day 1 after hemorrhoidectomy [Postoperative day 1]

    Pain score on postoperative day from scale of 1 to 10 after hemorrhoidectomy.

Secondary Outcome Measures

  1. Postoperative complications after hemorrhoidectomy [Within 30 days after surgery]

    Postoperative bleeding, urinary retention, perianal sepsis, anal stenosis, incontinence

  2. Proportion of patients who had admission after day surgery or readmission for postoperative complications [Within 30 days after surgery]

    Proportion of patients who had readmission or required admission after surgery.

  3. Proportion of patients who require repeat surgical interventions for postoperative complications: bleeding, perianal sepsis and anal stenosis [Within 30 days after surgery]

    Proportion of patients who required repeat surgical interventions after surgery.

  4. Changes in the mean pain score 1 month after surgery assessed by telephone interviews on POD1, 2, 3, 4, 7, 14, 21 and 28. [Postoperative day 1, 2, 3, 4, 7, 14, 21 and 28.]

    Pain scores are recorded on the postoperative day 1, 2, 3, 4, 7, 14, 21 and 28 and postoperative pain score trends analyzed.

  5. Mean time to return to work or regular activity, in days, reported by the patient. [Within the first 90 days after the surgery]

    The time to return to work or regular activity after surgery as reported by the patient

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age group of patients: 21 to 75 years old

  2. Grade 3 (prolapsed but reducible manually) and Grade 4 (prolapsed but irreducible) piles that are symptomatic

  3. Patients recruited are to undergo either staple or conventional (Milligan-Morgan or Ferguson) haemorrhoidectomy

Exclusion Criteria:
  1. Grade 1 and 2 haemorrhoids

  2. Thrombosed, irreducible piles that require emergency haemorrhoidectomy

  3. Patients who had undergone any previous anorectal surgery within 5 years from the date of recruitment

  4. Patients with concurrent anorectal pathology (anal fissures, abscess, fistula, tumour, inflammatory bowel disease)

  5. Pregnant women

  6. Patients with severe medical comorbidities or assessed as ASA 3 and above

  7. Patients on long term antiplatelets (aspirin, plavix) and anticoagulation (clexane, warfarin, rivaroxaban, apixaban)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Singapore General Hospital Singapore Singapore 169608

Sponsors and Collaborators

  • Singapore General Hospital

Investigators

  • Principal Investigator: Isaac Seow-En, Singapore General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Singapore General Hospital
ClinicalTrials.gov Identifier:
NCT06005727
Other Study ID Numbers:
  • 2022/2357
First Posted:
Aug 22, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2023